Annual Revenue
$622.00 K
+$382.00 K+159.17%
31 December 2023
Summary:
ImmunityBio annual revenue is currently $622.00 thousand, with the most recent change of +$382.00 thousand (+159.17%) on 31 December 2023. During the last 3 years, it has fallen by -$312.00 thousand (-33.40%). IBRX annual revenue is now -71.75% below its all-time high of $2.20 million, reached on 31 December 2019.IBRX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$6.11 M
+$5.06 M+483.19%
30 September 2024
Summary:
ImmunityBio quarterly revenue is currently $6.11 million, with the most recent change of +$5.06 million (+483.19%) on 30 September 2024. Over the past year, it has increased by +$5.97 million (+4292.81%). IBRX quarterly revenue is now at all-time high.IBRX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$7.33 M
+$6.02 M+460.55%
30 September 2024
Summary:
ImmunityBio TTM revenue is currently $7.33 million, with the most recent change of +$6.02 million (+460.55%) on 30 September 2024. Over the past year, it has increased by +$6.71 million (+1078.78%). IBRX TTM revenue is now at all-time high.IBRX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IBRX Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +4292.8% | +1078.8% |
| 3 y3 years | -33.4% | +1465.6% | +685.0% |
| 5 y5 years | -71.8% | - | - |
IBRX Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -33.4% | +159.2% | at high | >+9999.0% | at high | +2955.0% |
| 5 y | 5 years | -71.8% | +159.2% | at high | +4253.7% | at high | +4343.6% |
| alltime | all time | -71.8% | +159.2% | at high | +4253.7% | at high | +4343.6% |
ImmunityBio Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.11 M(+483.2%) | $7.33 M(+460.6%) |
| June 2024 | - | $1.05 M(+2517.5%) | $1.31 M(+333.1%) |
| Mar 2024 | - | $40.00 K(-71.2%) | $302.00 K(-51.4%) |
| Dec 2023 | $622.00 K(+159.2%) | $139.00 K(+69.5%) | $622.00 K(+11.9%) |
| Sept 2023 | - | $82.00 K(+100.0%) | $556.00 K(-6.1%) |
| June 2023 | - | $41.00 K(-88.6%) | $592.00 K(+1.0%) |
| Mar 2023 | - | $360.00 K(+393.2%) | $586.00 K(+144.2%) |
| Dec 2022 | $240.00 K | $73.00 K(-38.1%) | $240.00 K(-56.9%) |
| Sept 2022 | - | $118.00 K(+237.1%) | $557.00 K(+10.3%) |
| June 2022 | - | $35.00 K(+150.0%) | $505.00 K(-37.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $14.00 K(-96.4%) | $809.00 K(-13.4%) |
| Dec 2021 | $934.00 K(+54.4%) | $390.00 K(+490.9%) | $934.00 K(+135.3%) |
| Sept 2021 | - | $66.00 K(-80.5%) | $397.00 K(-17.6%) |
| June 2021 | - | $339.00 K(+143.9%) | $482.00 K(-16.8%) |
| Mar 2021 | - | $139.00 K(-194.6%) | $579.00 K(-4.3%) |
| Dec 2020 | $605.00 K(-72.5%) | -$147.00 K(-197.4%) | $605.00 K(-19.5%) |
| Sept 2020 | - | $151.00 K(-65.4%) | $752.00 K(+25.1%) |
| June 2020 | - | $436.00 K(+164.2%) | $601.00 K(+264.2%) |
| Mar 2020 | - | $165.00 K | $165.00 K |
| Dec 2019 | $2.20 M | - | - |
FAQ
- What is ImmunityBio annual revenue?
- What is the all time high annual revenue for ImmunityBio?
- What is ImmunityBio quarterly revenue?
- What is the all time high quarterly revenue for ImmunityBio?
- What is ImmunityBio quarterly revenue year-on-year change?
- What is ImmunityBio TTM revenue?
- What is the all time high TTM revenue for ImmunityBio?
- What is ImmunityBio TTM revenue year-on-year change?
What is ImmunityBio annual revenue?
The current annual revenue of IBRX is $622.00 K
What is the all time high annual revenue for ImmunityBio?
ImmunityBio all-time high annual revenue is $2.20 M
What is ImmunityBio quarterly revenue?
The current quarterly revenue of IBRX is $6.11 M
What is the all time high quarterly revenue for ImmunityBio?
ImmunityBio all-time high quarterly revenue is $6.11 M
What is ImmunityBio quarterly revenue year-on-year change?
Over the past year, IBRX quarterly revenue has changed by +$5.97 M (+4292.81%)
What is ImmunityBio TTM revenue?
The current TTM revenue of IBRX is $7.33 M
What is the all time high TTM revenue for ImmunityBio?
ImmunityBio all-time high TTM revenue is $7.33 M
What is ImmunityBio TTM revenue year-on-year change?
Over the past year, IBRX TTM revenue has changed by +$6.71 M (+1078.78%)